Anthem Biosciences has released the audio recording of its Earnings Call for the quarter and half year ending September 30, 2025. The call took place on November 10, 2025, and included discussions on the company's Unaudited Standalone and Consolidated Financial Results. Investors and analysts can access the recording through the company's website at [https://www.anthembio.com/investor.html](https://www.anthembio.com/investor.html). This release is in compliance with Regulation 30 and Regulation 46 of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015.

The announcement was formally communicated to both the BSE Limited and the National Stock Exchange of India Limited, where Anthem Biosciences is listed under the scrip code 544449 and symbol ANTHEM, respectively. The company, formerly known as Anthem Biosciences Private Limited, aims to keep stakeholders informed about its financial performance and strategic direction. This transparency is crucial for investors as they analyze the company's progress and future prospects. Divya Prasad, the Company Secretary and Compliance Officer, signed off on the communication, thanking the recipients for their attention to this important update.